The primary role of tesamorelin is to stimulate the release of growth hormone-releasing hormone (GHRH) from the hypothalamus. GHRH then triggers the pituitary gland to produce more growth hormone, which plays a crucial role in cell regeneration, metabolism regulation, muscle mass development, bone density maintenance, and other essential bodily functions.
Beyond reducing VAT, other positive outcomes from these studies included decreased trunk fat and increased lean body mass. Additionally, self-reported improvements in overall appearance and body image perception were noted among those treated with tesamorelin.
By promoting growth hormone production through peptide therapy using tesamorelin, middle-aged men and women can potentially experience improvements not only in body composition but also in critical aspects related to overall wellness, such as healthy lipid profile maintenance and better glycemic control.